Technology & Telecommunication Services » Software | Tyche Industries Ltd.

Tyche Industries Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
81,570.90
28,617.00
25,515.00
59,269.50
-
-
Depreciation, Depletion & Amortization
14,064.00
33,428.90
17,613.10
18,701.40
-
-
Other Funds
21,541.30
12,269.00
6,530.30
22,922.30
-
-
Funds from Operations
74,093.70
49,777.00
36,597.70
55,048.50
77,082.00
-
Changes in Working Capital
20,946.90
24,657.10
84,490.20
63,546.40
-
-
Net Operating Cash Flow
95,040.50
25,119.90
121,087.90
118,595.00
-
-
Capital Expenditures
67,790.90
10,409.90
13,047.90
703.40
-
Sale of Fixed Assets & Businesses
7.00
585.70
1,646.70
290.00
-
Net Investing Cash Flow
68,688.30
11,799.70
14,923.70
1,103.20
-
Cash Dividends Paid - Total
5,945.20
6,156.80
6,145.20
6,145.20
-
Issuance/Reduction of Debt, Net
6,269.40
26,195.80
22,027.10
99,768.20
-
Net Financing Cash Flow
324.10
32,352.50
15,881.90
105,913.40
-
Net Change in Cash
26,676.40
19,032.30
122,046.00
13,784.70
-
Free Cash Flow
27,249.70
14,710.10
108,040.00
117,891.60
-
Other Sources
-
-
1,383.10
4,102.80
-
Other Uses
904.40
1,975.50
4,905.60
2,586.30
-

About Tyche Industries

View Profile
Address
H. No. C21/A, Road No. 9
Hyderabad TS 500096
India
Employees -
Website http://www.tycheindustries.com
Updated 07/08/2019
Tyche Industries Ltd. engages in the manufacture of active pharmaceutical ingredient and intermediates. It offers a range of products including Chiral intermediates and nutraceuticals for the treatment of various diseases including diarrhea, emetic, benign prostatic hypertrophy, retroviral, arthritis, inflammatory, microbacteria, and osteoporosis. The company was founded on July 23, 1998 and is headquartered in Hyderabad, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.